{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:50:32Z","timestamp":1790488232914,"version":"4.1.0"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Paediatric optic pathway gliomas are low-grade brain tumours characterized by slow progression and invalidating visual loss. Presently there is no strategy to prevent visual loss in this kind of tumour. This study evaluated the effects of nerve growth factor administration in protecting visual function in patients with optic pathway glioma-related visual impairment. A prospective randomized double-blind phase II clinical trial was conducted in 18 optic pathway glioma patients, aged from 2 to 23 years, with stable disease and severe visual loss. Ten patients were randomly assigned to receive a single 10-day course of 0.5 mg murine nerve growth factor as eye drops, while eight patients received placebo. All patients were evaluated before and after treatment, testing visual acuity, visual field, visual-evoked potentials, optic coherence tomography, electroretinographic photopic negative response, and magnetic resonance imaging. Post-treatment evaluations were repeated at 15, 30, 90, and 180 days Brain magnetic resonance imaging was performed at baseline and at 180 days. Treatment with nerve growth factor led to statistically significant improvements in objective electrophysiological parameters (electroretinographic photopic negative response amplitude at 180 days and visual-evoked potentials at 30 days), which were not observed in placebo-treated patients. Furthermore, in patients in whom visual fields could still be measured, visual field worsening was only observed in placebo-treated cases, while three of four nerve growth factor-treated subjects showed significant visual field enlargement. This corresponded to improved visually guided behaviour, as reported by the patients and\/or the caregivers. There was no evidence of side effects related to nerve growth factor treatment. Nerve growth factor eye drop administration appears a safe, easy and effective strategy for the treatment of visual loss associated with optic pathway gliomas.<\/jats:p>","DOI":"10.1093\/brain\/awv366","type":"journal-article","created":{"date-parts":[[2016,1,15]],"date-time":"2016-01-15T12:42:15Z","timestamp":1452861735000},"page":"404-414","source":"Crossref","is-referenced-by-count":51,"title":["Nerve growth factor improves visual loss in childhood optic gliomas: a randomized, double-blind, phase II clinical trial"],"prefix":"10.1093","volume":"139","author":[{"given":"Benedetto","family":"Falsini","sequence":"first","affiliation":[{"name":"1 Institute of Ophthalmology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Chiaretti","sequence":"additional","affiliation":[{"name":"2 Paediatric Oncology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rizzo","sequence":"additional","affiliation":[{"name":"2 Paediatric Oncology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Piccardi","sequence":"additional","affiliation":[{"name":"1 Institute of Ophthalmology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ruggiero","sequence":"additional","affiliation":[{"name":"2 Paediatric Oncology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Manni","sequence":"additional","affiliation":[{"name":"3 Institute of Translational Pharmacology, CNR, 00142 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Soligo","sequence":"additional","affiliation":[{"name":"3 Institute of Translational Pharmacology, CNR, 00142 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dickmann","sequence":"additional","affiliation":[{"name":"1 Institute of Ophthalmology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Federici","sequence":"additional","affiliation":[{"name":"1 Institute of Ophthalmology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabella","family":"Salerni","sequence":"additional","affiliation":[{"name":"1 Institute of Ophthalmology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Timelli","sequence":"additional","affiliation":[{"name":"4 Informa Society, 00135 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaspare","family":"Guglielmi","sequence":"additional","affiliation":[{"name":"5 Pharmacy Gemelli Hospital, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lazzareschi","sequence":"additional","affiliation":[{"name":"2 Paediatric Oncology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Caldarelli","sequence":"additional","affiliation":[{"name":"6 Paediatric Neurosurgery, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Galli-Resta","sequence":"additional","affiliation":[{"name":"7 Institute of Neuroscience, CNR, 56121 Pisa, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Colosimo","sequence":"additional","affiliation":[{"name":"8 Institute of Radiology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Riccardi","sequence":"additional","affiliation":[{"name":"2 Paediatric Oncology, Universit\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"2019071112555302600_awv366-B1","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1167\/iovs.14-16235","article-title":"Functional loss of the inner retina in childhood optic gliomas detected by photopic negative response","volume":"56","author":"Abed","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019071112555302600_awv366-B3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ajo.2010.08.046","article-title":"Retinal nerve fiber layer thickness in children with optic pathway gliomas","volume":"151","author":"Avery","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"2019071112555302600_awv366-B4","doi-asserted-by":"crossref","first-page":"39392","DOI":"10.1074\/jbc.M110.147801","article-title":"Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism","volume":"285","author":"Bai","year":"2010","journal-title":"J Biol Chem"},{"key":"2019071112555302600_awv366-B5","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC-07\/11\/E2","article-title":"Optic pathway gliomas: a review","volume":"23","author":"Binning","year":"2007","journal-title":"Neurosurg Focus"},{"key":"2019071112555302600_awv366-B6","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0960-9822(00)00713-2","article-title":"Brain-derived neurotrophic factor is an anterograde survival factor in the rat visual system","volume":"10","author":"Caleo","year":"2000","journal-title":"Curr Biol"},{"key":"2019071112555302600_awv366-B7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/jop.2010.0139","article-title":"Time-dependent activation of c-fos in limbic brain areas by ocular administration of nerve growth factor in adult rats","volume":"27","author":"Calza","year":"2011","journal-title":"J Ocul Pharmacol Ther"},{"key":"2019071112555302600_awv366-B9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3233\/JAD-2009-0953","article-title":"Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice","volume":"16","author":"Capsoni","year":"2009","journal-title":"J Alzheimer\u2019s Dis"},{"key":"2019071112555302600_awv366-B10","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/0014-4886(91)90097-V","article-title":"Expression of NGF receptor mRNA in the developing and adult rat retina","volume":"111","author":"Carmignoto","year":"1991","journal-title":"Exp Neurobiol"},{"key":"2019071112555302600_awv366-B11","first-page":"966","article-title":"BDNF enhances retinal ganglion cell survival in cats with optic nerve damage","volume":"42","author":"Chen","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019071112555302600_awv366-B12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s00381-004-0959-6","article-title":"Neurotrophic factor expression in childhood low-grade astrocytomas and ependymomas","volume":"20","author":"Chiaretti","year":"2004","journal-title":"Childs Nerv Syst"},{"key":"2019071112555302600_awv366-B13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1179\/016164107X247948","article-title":"Intraventricular nerve growth factor infusion improves cerebral blood flow and stimulates doublecortin expression in two infants with hypoxic-ischemic brain injury","volume":"30","author":"Chiaretti","year":"2008","journal-title":"Neurol Res"},{"key":"2019071112555302600_awv366-B14","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/1545968310395601","article-title":"Nerve growth factor eye drop administration improves visual function in a patient with optic glioma","volume":"25","author":"Chiaretti","year":"2011","journal-title":"Neurorehabil Neural Repair"},{"key":"2019071112555302600_awv366-B15","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s00417-008-0913-5","article-title":"Retinal p75 and bax over expression is associated with retinal ganglion cells apoptosis in a rat model of glaucoma","volume":"246","author":"Coassin","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2019071112555302600_awv366-B16","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000017069","article-title":"Intracerebroventricular infusion of Nerve Growth Factor in three patients with Alzheimer\u2019s disease","volume":"9","author":"Eriksdotter J\u00f6nhagen","year":"1998","journal-title":"Dement Geriatr Cogn Disord"},{"key":"2019071112555302600_awv366-B17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11060-008-9537-1","article-title":"Longitudinal assessment of childhood optic gliomas: relationship between flicker visual evoked potentials and magnetic resonance imaging findings","volume":"88","author":"Falsini","year":"2008","journal-title":"J Neurooncology"},{"key":"2019071112555302600_awv366-B18","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1177\/1545968310397201","article-title":"Topical nerve growth factor as a visual rescue strategy in pediatric optic gliomas: a pilot study including electrophysiology","volume":"25","author":"Falsini","year":"2011","journal-title":"Neurorehabil Neural Repair"},{"issue":"21 Suppl 1","key":"2019071112555302600_awv366-B19","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/01.wnl.0000435745.95155.b8","article-title":"Functional outcome measures for NF1-associated optic pathway glioma clinical trials","volume":"81","author":"Fisher","year":"2013","journal-title":"Neurology"},{"key":"2019071112555302600_awv366-B20","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0079-6123(01)34004-9","article-title":"BDNF\/trkB signaling in the developmental sculpting of visual connections","volume":"134","author":"Frost","year":"2001","journal-title":"Prog Brain Res"},{"key":"2019071112555302600_awv366-B21","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1046\/j.1460-9568.2000.00213.x","article-title":"Differential effects of neurotrophins on ocular dominance plasticity in developing and adult cat visual cortex","volume":"12","author":"Galuske","year":"2000","journal-title":"Eur J Neurosci"},{"key":"2019071112555302600_awv366-B23","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1167\/iovs.13-13119","article-title":"Ganglion cell layer-inner plexiform layer thickness and vision loss in young children with optic pathway gliomas","volume":"55","author":"Gu","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019071112555302600_awv366-B24","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/NEN.0b013e3181a3240b","article-title":"Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma","volume":"68","author":"Hegedus","year":"2009","journal-title":"J Neuropathol Exp Neurol"},{"key":"2019071112555302600_awv366-B25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/pbc.24726","article-title":"Visual acuity of children treated with chemotherapy for optic pathway gliomas","volume":"61","author":"Kalin-Hajdu","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"2019071112555302600_awv366-B26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2010.06.017","article-title":"Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma","volume":"170","author":"Kim","year":"2010","journal-title":"Neuroscience"},{"key":"2019071112555302600_awv366-B27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/glia.1040","article-title":"Serum deprivation and NGF induce and modulate voltage-gated Na(+) currents in human astrocytoma cell lines","volume":"34","author":"Kraft","year":"2001","journal-title":"Glia"},{"key":"2019071112555302600_awv366-B28","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.1167\/iovs.05-0301","article-title":"Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats","volume":"46","author":"Lambiase","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019071112555302600_awv366-B29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phrs.2007.03.007","article-title":"NGF topical application in patients with corneal ulcer does not generate circulating NGF antibodies","volume":"56","author":"Lambiase","year":"2007","journal-title":"Pharmacol Res"},{"key":"2019071112555302600_awv366-B30","doi-asserted-by":"crossref","first-page":"13469","DOI":"10.1073\/pnas.0906678106","article-title":"Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma","volume":"106","author":"Lambiase","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019071112555302600_awv366-B31","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1358\/dnp.2010.23.6.1472299","article-title":"Nerve growth factor eye drops to treat glaucoma","volume":"23","author":"Lambiase","year":"2010","journal-title":"Drug News Perspect"},{"key":"2019071112555302600_awv366-B32","doi-asserted-by":"crossref","first-page":"4651","DOI":"10.1523\/JNEUROSCI.12-12-04651.1992","article-title":"Nerve growth factor (NGF) prevents the shift in ocular dominance distribution of visual cortical neurons in monocularly deprived rats","volume":"12","author":"Maffei","year":"1992","journal-title":"J Neurosci"},{"key":"2019071112555302600_awv366-B34","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1016\/j.ejca.2010.03.028","article-title":"Does chemotherapy affect the visual outcome in children with optic pathway glioma? A systematic review of the evidence","volume":"46","author":"Moreno","year":"2010","journal-title":"Eur J Cancer"},{"key":"2019071112555302600_awv366-B36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1460-9568.1999.00417.x","article-title":"TrkA activation in the rat visual cortex by antirat trkA IgG prevents the effect of monocular deprivation","volume":"11","author":"Pizzorusso","year":"1999","journal-title":"Eur J Neurosci"},{"key":"2019071112555302600_awv366-B37","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/WNO.0b013e3182745600","article-title":"Retinal ganglion cell functional plasticity and optic neuropathy: a comprehensive model","volume":"32","author":"Porciatti","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"2019071112555302600_awv366-B39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1523\/JNEUROSCI.22-03-00912.2002","article-title":"Expression of the nerve growth factor receptors TrkA and p75NTR in the visual cortex of the rat: development and regulation by the cholinergic input","volume":"22","author":"Rossi","year":"2002","journal-title":"J Neurosci"},{"key":"2019071112555302600_awv366-B40","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1046\/j.1460-9568.1998.00227.x","article-title":"Nerve growth factor and brain-derived neurotrophic factor increase neurotransmitter release in the rat visual cortex","volume":"10","author":"Sala","year":"1998","journal-title":"Eur J Neurosci"},{"key":"2019071112555302600_awv366-B41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0006-8993(93)91164-N","article-title":"Protective effect of nerve growth factor against glutamate induced neurotoxicity in cultured cortical neurons","volume":"632","author":"Shimohama","year":"1993","journal-title":"Brain Res"},{"key":"2019071112555302600_awv366-B42","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2202-10-52","article-title":"Intravitreal NGF administration counteracts retina degeneration after permanent carotid occlusion in rat","volume":"10","author":"Sivilia","year":"2009","journal-title":"BMC Neuroscience"},{"key":"2019071112555302600_awv366-B43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/aps.2014.135","article-title":"Regulatory networks between neurotrophins and miRNAs in brain diseases and cancers","volume":"36","author":"Shi","year":"2015","journal-title":"Acta Pharmacol Sinica"},{"key":"2019071112555302600_awv366-B44","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/pbc.22967","article-title":"Visual outcome following chemotherapy for progressive optic pathway gliomas","volume":"57","author":"Shofty","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"2019071112555302600_awv366-B45","first-page":"3232","article-title":"Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia","volume":"34","author":"Siliprandi","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2019071112555302600_awv366-B46","first-page":"205","article-title":"The nerve growth factor administrated as eye drops activates mature and precursor cells in subventricular zone of adult rats","volume":"149","author":"Tirassa","year":"2011","journal-title":"Arch Ital Biol"},{"key":"2019071112555302600_awv366-B47","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1097\/00001756-200207190-00031","article-title":"Rat visual cortical neurones express TrkA NGF receptor","volume":"13","author":"Tropea","year":"2002","journal-title":"Neuroreport"},{"key":"2019071112555302600_awv366-B48","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1523\/JNEUROSCI.12-10-04011.1992","article-title":"Colocalization of NGF binding sites, trkA mRNA, and low-affinity NGF receptor mRNA in primary sensory neurons: responses to injury and infusion of NGF","volume":"12","author":"Verge","year":"1992","journal-title":"J Neurosci"},{"key":"2019071112555302600_awv366-B49","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1023\/A:1019919019497","article-title":"Growth control of C6 glioma in vivo by nerve growth factor","volume":"59","author":"Verge","year":"2002","journal-title":"J Neurooncology"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/139\/2\/404\/28929035\/awv366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T16:56:17Z","timestamp":1562864177000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/139\/2\/404\/1754052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,14]]},"published-print":{"date-parts":[[2016,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awv366","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2016,2]]},"published":{"date-parts":[[2016,1,14]]}}}